Kimberly-Clark says China disruption will take time to resolve

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights

Kimberly-Clark Corp. delivered a Q2 EPS beat of $2.12 against a $2.01 estimate, driven by gross margin expansion to 38.3% and operating profit growth of 6.2%. Revenue of $4.189 billion missed consensus due to social media-driven sales disruption in China. Management acknowledges the issue will take time to resolve but remains confident in its ability to navigate the headwind, supported by strong cash flow and reduced debt.

powered bylight_fuzz_icon
47388127

*this image is generated using AI for illustrative purposes only.

Kimberly-Clark Corp. executives acknowledged that the sales disruption in China, driven by false social media allegations regarding diaper quality, will require time to fully resolve. Despite this ongoing headwind, management expressed confidence in the company’s ability to navigate the situation. This commentary follows the company’s second-quarter results, where adjusted earnings per share of $2.12 beat the $2.01 analyst estimate, even as revenue of $4.189 billion missed the $4.221 billion consensus due to the China impact.

The maker of Huggies and Kleenex reported a 0.6% year-over-year revenue increase for Q2FY26. While top-line growth was modest, profitability remained strong with adjusted operating profit rising 6.2% to $757 million. Gross margin expanded significantly to 38.3% from 35.0% a year earlier, aided by tariff refunds and productivity savings that offset investments in new product trials and supply chain operations. Independent government-certified testing has confirmed the safety and quality of Kimberly-Clark’s products in China, yet the false claims continue to weigh on diaper sales.

Regional Performance and Operational Metrics

North America revenue declined 1.2% to $2.70 billion, reflecting the exit of the private-label diaper business and inventory-related headwinds. Conversely, International Personal Care revenue rose 4.0% to $1.49 billion, supported by favorable currency effects and volume growth, despite the China disruption. Chairman and CEO Mike Hsu stated that the first-half performance demonstrates the acceleration of the company’s operating model transformation while maintaining momentum across its brands.

Metric Q2 Value Change Note
Revenue $4.189 billion +0.6% YoY Missed $4.221B estimate
Adjusted EPS $2.12 +10.4% YoY Beat $2.01 estimate
Gross Margin 38.3% +330 bps YoY From 35.0%
Adj. Operating Profit $757 million +6.2% YoY Driven by productivity

Balance Sheet and Cash Flow

Cash and cash equivalents totaled $956 million as of June 30, 2026. Six-month operating cash flow reached $1.7 billion, up from $1.1 billion last year, indicating strong cash generation despite the headwinds. Year-to-date capital spending increased significantly to $776 million compared to $401 million last year, reflecting continued investment in innovation and productivity. Dividend payouts totaled $843 million during the period. Total debt from continuing operations decreased to $6.5 billion on June 30, down from $7.2 billion on December 31, highlighting improved leverage.

Outlook and Management Commentary

For the full year 2026, Kimberly-Clark expects organic sales growth to trail its weighted average category growth by approximately 100 basis points, primarily due to the China-related disruption. The company continues to project mid-single-digit growth in adjusted operating profit on a constant-currency basis and high single-digit growth in adjusted EPS from continuing operations. However, adjusted EPS attributable to Kimberly-Clark is now expected to decline by a low single-digit percentage on a constant-currency basis, reflecting the persistent drag from China. Executives emphasized they are realistic about the timeline required to work through the issue but remain confident in their navigation strategy.

What the Numbers Show

The divergence between the strong Q2 adjusted EPS beat and the missed revenue target underscores the effectiveness of Kimberly-Clark’s cost management and productivity initiatives. While operational profitability remains robust with a 6.2% increase in adjusted operating profit, the China disruption serves as a critical headwind for top-line growth. The substantial improvement in operating cash flow and reduction in total debt provide financial flexibility to navigate these near-term challenges and support sustainable growth beyond 2026.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific strategic initiatives is Kimberly-Clark deploying to counteract the persistent social media misinformation and restore consumer trust in its diaper brands within the Chinese market?

How might the 100 basis points drag on organic sales growth in China impact Kimberly-Clark's ability to meet its mid-single-digit adjusted operating profit guidance for the full year 2026?

Given the significant increase in year-to-date capital spending to $776 million, which specific innovation or productivity projects are expected to yield the highest return on investment post-2026?

like20
dislike

UBS raises Kimberly-Clark price target to $115

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

UBS analyst Peter Grom maintains a Neutral rating on Kimberly-Clark (NASDAQ:KMB) and raises the price target to $115 from $106, indicating a revised valuation.

powered bylight_fuzz_icon
45775188

*this image is generated using AI for illustrative purposes only.

UBS analyst Peter Grom has maintained a Neutral rating on Kimberly-Clark (NASDAQ:KMB) while raising the price target to $115 from $106. The adjustment reflects a revised valuation outlook for the consumer goods company.

Rating and Price Target Details

The research note updates the investment stance on Kimberly-Clark without altering the Neutral recommendation. The new price target represents an increase from the previous level of $106.

Metric Value
Rating Neutral
Previous Price Target $106
New Price Target $115

The revised target suggests a specific upside potential based on the current trading price of Kimberly-Clark shares.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific valuation metrics drove the decision to raise the price target while maintaining a Neutral rating?

How might Kimberly-Clark's upcoming earnings report influence UBS's stance on the stock?

What are the key risks or opportunities that could shift the rating from Neutral in the near term?

like17
dislike

More News on Kimberly Clark